In the “Q”
Vol. 1 Urological Materials and Devices
Vol. 1 Urological Materials and Devices
Introduction To accomplish a reliable transition between two TPU differential durometer components the primary objective is the application of optimized localized process temperatures. Generally speaking, this is accomplished when polymer properties are allowed to exhibit an even distribution of amorphous hard and soft segment in the molecular architecture in process, see Figure 3.0. Although normalization…
Read more
Introduction Segmenting and lamination process technologies result in varied proportions of modulus exhibited at specific axial and or circumferential designations. This is possible due to specific thermal process parameters and tooling with respect to materials used. Materials Products can exhibit superior physical characteristics due to their synergy of optimized processes for specificmaterials, which results in…
Read more
According to some sources, catheter and stent manufacturers are crying out for the perfect material to stop devices sticking to (human tissue). Existing technologies and materials are cumbersome, some urological sources say, and coatings are expensive and involve extra manufacturing steps. CEO and founder of Q Urological, Scott Epstein, claims to have developed the “perfect”…
Read more
On January 6,2017, Amanda Pedersen of Qmed wrote an article on Scott Epstein, founder and CEO of Q Urological, and his journey to develop new urological products that address the clearly defined complications with current market products. Qmed, (2017). How One Entrepreneur Took The Road Less Traveled. [online] Available at: https://www.mddionline.com/how-one-entrepreneur-took-road-less-traveled
On February 19, 2014, MPN wrote an article about the AguamedicinaTM structural hydrogel ureteral stent and its advantage over current devices with emphasis on increased comfort, safety and efficacy. The article also references a Boston Children Hospital study evaluating biofilm growth and bacterial resistant properties of Q Urological AguamedicinaTM pediatric ureteral stents compared to Boston…
Read more
On August 12, 2013, MPN wrote an article about hydrogels and their advantages over current market products when used for various medical applications. The article highlights the hydrogel-based bandage (Hydress) developed by Alliqua, inc. and references the Aguamedicina pediatric ureteral stent developed by Q Urological. Medical Plastics News, (2013). Building a Better Bandage: Why Hydrogels…
Read more
On August 24, 2012, Patricia Resende of the Boston Business Journal wrote an article on the background of Q Urological and the future of the company as they prepare to bring their Aguamedicina pediatric ureteral stent to market. Boston Business Journal, (2012). Q Urological prepares to bring stent to market. [online] Available at: https://www.bizjournals.com/boston/blog/mass-high-tech/2012/08/q-urological-prepares-to-bring-stent.html
On January 28, 2011, Scott Epstein, CEO and Founder at Q Urological Corporation spoke with MYOB co-hosts Rick Brutti and Jeffrey S. Davis about the urological medical device market. The discussion focuses on the current urology market and its lack of substantial development over the past 30 years. The Q Urological background is also discussed…
Read more